Psychoendocrinology of anxiety disorders;Psychoendokrinologie der angst

Psychologische Rundschau

Volumn 57, Issue 3, 2006, Pages 165-175

  Ehlert, Ulrike ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Anxiety disorders; Diagnostic procedures; Fear; Genetics; Intervention; Psychoendocrinology

Indexed keywords

EID: 33746227688     PISSN: 00333042     EISSN: None     Source Type: Journal    
DOI: 10.1026/0033-3042.57.3.165     Document Type: Review

References (105)

1. Abelson, J. L. & Curtis, G. C. (1996). Hypothalamic-pituitaryadrenal axis activity in panic disorder. 24-hour secretion of corticotropin and Cortisol. Archives of General Psychiatry, 53, 323-331.
2. Alpers, G. W., Abelson J. L., Wilhelm F. H. & Roth, W. T. (2003). Salivary cortisol response during exposure treatment in driving phobics. Psychosomatic Medicine, 65, 679-687.
3. Alpers, G. W., Sell, R. & Pauli, P. (2006). Cortisol response during exposure therapy in claustrophobia. Manuscript in preparation.
4. Bachmann, A. W., Sedgley, T. L., Jackson, R. V., Gibson, J. N., Young, R. M. & Torpy, D. J. (2005). Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology, 30, 297-306.
5. Baker, D. G., West, S. A., Orth, D. N., Hill, K. K., Nicholson, W. E., Ekhator, N. N., Bruce, A. B., Wortman, M. D., Keck, P. E. & Geracioti, T. D. (1997). Cerospinal fluid and plasma β-endorphin in combat veterans with post-traumatic stress disorder. Psychoneuroendocrinology, 22, 517-529.
6. Bandelow, B., Wedekind, D., Pauls, J., Broocks, A., Hajak, G. & Rüther, E. (2000a). Salivary cortisol in panic attacks. The American Journal of Psychiatry, 157, 454-456.
7. Bandelow, B., Wedekind, D., Sandvoss, V., Broocks, A., Hajak, G., Pauls, J., Peter, H. & Ruther E. (2000b). Diurnal variation of cortisol in panic disorder. Psychiatry Research, 95, 245-250.
8. Barsky, A. J. & Wyshak, G. (1990). Hypochondriasis and somatosensory amplification. British Journal of Psychiatry, 157, 404-409.
9. Bauer, M., Priebe, S., Graf, K. J., Kurten, I. & Baumgartner, A. (1994). Psychological and endocrine abnormalities in refugees from East Germany: Part II. Serum levels of cortisol, prolactin, luteinizing hormone, follicle stimulating hormone, and testosterone. Psychiatry Research, 51, 75-85.
10. Benjamins, C., Asscheman, H. & Schuurs, A. H. (1992). Increased salivary cortisol in severe dental anxiety. Psychophysiology, 29, 302-305.
11. Blanchard, E. B., Kolb, L. C. & Prins, A. (1991). Changes in plasma norepinephrine to combat-related stimuli among Vietnam veterans with posttraumatic stress disorder. The Journal of Nervous and Mental Disease, 179, 371-373.
12. 2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviours (SAB). Molecular Psychiatry, 2, 239-246.
13. Brambilla, F. (2000). Psychoneuroendocrinology: a science of the past or a new pathway for the future? European Journal of Pharmacology, 405, 341-349.
14. Brambilla, F., Bellodi, L., Perna, G., Battaglia, M., Sciuto, G., Diaferia, G., Petraglia, F., Panerai, A. & Sacerdote, P. (1992). Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology, 26, 12-22.
15. Brambilla, F., Biggio, G., Pisu, M. G., Bellodi, L., Perna, G., Bogdanovich-Djukic, V., Purdy, R. H. & Serra, M. (2003). Neurosteroid secretion in panic disorder. Psychiatry Research, 118, 107-116.
16. Brand, H. S., Gortzak, R. A., Palmer-Bouva, C. C., Abraham, R. E. & Abraham-Inpjin, L. (1995). Cardiovascular and neuroendocrine responses during acute stress induced by different types of dental treatment. International Dental Journal, 45, 45-48.
17. Bremner, J. D., Licinio, J., Darnell, A., Krystal, J. H., Owens, M. J., Southwick, S. M., Nemeroff, C. B. & Charney, D. S. (1997). Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. The American Journal of Psychiatry, 154, 624-629.
18. Buss, C., Wolf, O. T. Wirt, J. & Hellhammer, D. H. (2004). Autobiographic memory impairment following acute cortisol administration. Psychoneuroendocrinology, 29, 1093-1096.
19. Cameron, O. G., Abelson, J. L. & Young, E. A. (2004). Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function. Biological Psychiatry, 56, 875-883.
20. Cameron, O. G. Kuttesch, D., McPhee, K. & Curtis, G. C. (1988). Menstrual fluctuation in the symptoms of panic anxiety. Journal of Affective Disorders, 15, 169-174.
21. Caspi, A., Sugden, K., Moffit, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Braithwaite, A. & Poulton, R. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301, 291-293.
22. Condren, R. M., O'Neill, A., Ryan, M. C. M., Barrett, P. & Thakore, J. H. (2002). HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinology, 27, 693-703.
23. Connor, K. M. & Davidson, J. R. T. (1998). Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biological Psychiatry, 44, 1286-1294.
24. Cook, B. L., Noyes, R. Jr., Garvey, M. J., Beach V., Sobotka, J. & Chaudhry, D. (1990). Anxiety and the menstrual cycle in panic disorder. Journal of Affective Disorders, 19, 221-226.
25. Cooper, M. A. & Ritchie, E. C. (2000). Testosterone replacement therapy for anxiety. The American Journal of Psychiatry, 157, 1884.
26. Coryell, W., Noyes, R. Jr. & Schlechte, J. (1989). The significance of HPA axis disturbance in panic disorder. Biological Psychology, 15, 989-1002.
27. Cottraux, J. & Claustrat, B. (1984). The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases. L'Encephale, 10, 267-272.
28. Duval, F., Crocq, M.-A., Guillon, M.-S., Mokrani, M.-C., Monreal, J., Bailey, P. & Macher, J.-P. (2004). Increased adrenocorticotropin suppression after dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Annals of the New York Academy of Sciences, 1032, 273-275.
29. Ehlert, U., Erni, K., Hebisch, G. & Nater, U. M. (2005). Effects of yohimbine challenge on salivary alpha-amylase secretion. Psychosomatic Medicine, 67, 92.
30. Ehlert, U., Gaab, J. & Heinrichs, M. (2001). Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder and stress-related bodily disorders: The role of the hypothalamus-pituitary-adrenal axis. Biological Psychology, 57, 141-152.
31. Ekeberg, O., Ellertsen, B. B., Seeberg, I. & Kjeldsen, S. E. (1989). Plasma catechoamines in some airline passengers. Scandinavian Journal of Clinical and Laboratory Investigation, 49, 183-188.
32. Ekeberg, O., Kjeldsen, S. E., Greenwood, D. T. & Enger, E. (1990). Correlations between psychological and physiological responses to acute flight phobia stress. Scandinavian Journal of Clinical and Laboratory Investigation, 50, 671-677.
33. Fisher, P. A., Gunnar, M. R., Chamberlain, P. & Reid, J. B. (2000). Preventive intervention for maltreated preschool children: Impact and children's behaviour, neuorendocrine activity, and foster parent functioning. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1356-1364.
34. Furlan, P. M., DeMartinis, N., Schweizer, E., Rickels, K. & Lucki, I. (2001). Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress. Biological Psychiatry, 50, 254-259.
35. Gaab, J., Blättler, N., Stoyer, S., Menzi, T., Pabst, B. & Ehlert, U. (2003). Randomized controlled evaluation of the effects of cognitive-behavioral stress management on cortisol responses to acute stress in healthy subjects. Psychoneuroendocrinology, 28, 767-779.
36. Gaab, J., Jucker, P., Staub, F. & Ehlert, U. (2005a). Mind over matter: Psychobiologische Effekte einer Konfrontationstherapie bei Spinnenangst. Zeitschrift für Klinische Psychologie und Psychotherapie, 32, 121-132.
37. Gaab J., Rohleder, N., Nater, U. M. & Ehlert, U. (2005b). Psychological determinants of the neuroendocrine stress response. Psychneuroendocrinology, 30, 599-610.
38. Garcia-Leal, C., Parente, A. C. B. V., Del-Ben, C. M., Guimarães, F. S., Moreira, A. C., Elias, L. L. K. & Graeff, F. G. (2005). Anxiety and salivary Cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking. Psychiatry Research, 133, 239-252.
39. Geer, H. J. (1965). The development of a scale to measure fear. Behaviour Research and Therapy, 3, 45-53.
40. Gelernter, J., Page, G. P., Bonvicini, K., Woods, S. W., Pauls, D. L. & Kruger, S. (2003). A chromosome 14 risk locus for simple phobia: Results from a genomewide linkage scan. Molecular Psychiatry, 8, 71-82.
41. Geracioti, T. D. Jr., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E. Jr. & Kasckow, J. W. (2001). CSF norepinephrine concentrations in posttraumatic stress disorder. American Journal of Psychiatry, 158, 1227-1230.
42. Gerra, G., Zaimovic, A., Zambelli, U., Timpano, M., Reali, N., Bernasconi, S. & Brambilla, F. (2000). Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology, 42, 82-92.
43. Goldstein, A. J. & Chambless, D. L. (1978). A reanalysis of agoraphobia. Behavior Therapy, 9, 47-59.
44. Grillon, C., Southwick, S. M. & Charney, D. S. (1996). The psychobiological basis of posttraumatic stress disorder. Molecular Psychiatry, 1, 278-297.
45. Hammerfald, K., Eberle, C., Grau, M., Kinsperger, A., Zimmermann, A., Ehlert, U. & Gaab, J. (2005). Persistent effects of cognitive-behavioral stress management on cortisol responses to acute stress in healthy subjects-A randomized controlled trial. Psychoneuroendocrinology 30, Epub ahead of print.
46. Heim, C. & Ehlert, U. (1999). Pharmakologische Provokationstests zur Einschätzung der neuroendokrinen Funktion. In C. Kirschbaum & D. Hellhammer (Hrsg.), Enzyklopädie der Psychologie: Themenbereich C Theorie und Forschung, Serie I Biologische Psychologie, Band 3, Psychoendokrinologie und Psychoimmunologie (S. 307-359). Göttingen: Hogrefe.
47. Heim, C., Ehlert, U., Hanker, J. P. & Hellhammer, D. H. (1998). Abuse related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosomatic Medicine, 60, 309-318.
48. Heim, C. & Meinlschmidt, G. (2003). Biologische Grundlagen. In: U. Ehlert (Hrsg.), Verhaltensmedizin (S. 17-94). Berlin: Springer.
49. Heinrichs, M., Baumgartner, T., Kirschbaum, C. & Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry, 54, 1389-1398.
50. Heinrichs, M., Wagner, D., Schoch, W., Soravia, L. M., Hellhammer, D. H. & Ehlert, U. (2005). Predicting posttraumatic stress disorder symptoms in a high-risk population: A 2-year prospective follow-up study in professional firefighters. American Journal of Psychiatry, 162, 2276-2286.
51. Hettema, J. M., Prescott, C. A. & Kendler, K. S. (2001). A population-based twin study of generalized anxiety disorder in men and women. The Journal of Nervous and Mental Disease, 189, 413-420.
52. Ho, H.-P., Westberg, L., Annerbrink, K., Olsson, M., Melke, J., Nilsson, S., Baghaei, F., Rosmond, R., Holm, G., Björntorp, P., Andersch, S., Allgulander, C. & Eriksson, E. (2004). Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinology, 29, 1138-1141.
53. Holmes, A., Heilig, M., Rupniak, N. M. J., Steckler, T. & Griebel, G. (2003). Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends in Pharmacological Sciences, 24, 580-588.
54. Huber, D., Veinante, P. & Stoop, R. (2005) Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science, 308, 245-248.
55. Kahn, R. S., Wetzler, S., Asnis, G. M., Kling, M. A., Suckow, R. F. & van Praag, H. M. (1991). Pituitary hormone responses to meta- chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Research, 37, 25-34.
56. Kathol, R. G., Noyes, R. Jr., Lopez, A. L. & Reich, J. H. (1988). Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Research, 24, 211-221.
57. Kendler, K. S., Gardner, C. O. & Prescott, C. A. (2001). Panic syndromes in a population-based sample of male and female twins. Psychological Medicine, 31, 989-1000.
58. Kendler, K. S., Karkowski, L. M. & Prescott, C. A. (1999). Fears and phobias: Reliability and heritability. Psychological Medicine, 29, 539-553.
59. Kendler, K. S., Neale, M. C., Kessler, R. C. Heath, A. C. & Eaves, L. J. (1992). Generalized anxiety disorder in women. A population-based twin study. Archives of General Psychiatry, 49, 267-272.
60. Kosten, T. R., Wahby, V., Giller, E. Jr. & Mason, J. (1990). The dexamethasone suppression test and thyrotropin releasing hormone stimulation test in posttraumatic stress disorder. Biological Psychiatry, 28, 657-664.
61. Krampen, G. (1994). Grundlagen und Strategien einer handlungs- theoretischen Persönlichkeitsdiagnostik. Trierer Psychologische Berichte, 21, Heft 4.
62. Krueger, T. H., Heller, H. W., Hauffa, B. P., Haake, P., Exton, M. S. & Schedlowski, M. (2005). The dental anxiety scale and effects of dental fear on salivary cortisol. Perceptual and motor skills, 100, 109-117.
63. Landgraf, R. & Neumann, I. D. (2004). Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Frontiers in Neuroendocrinology, 25, 150-176.
64. Lazarus, R. S. & Folkman, S. (1984). Stress, appraisal and coping. New York: Springer Publishing Company.
65. Li, D., Chokka, P. & Tibbo, P. (2001). Toward an integrative understanding of social phobia. Journal of Psychiatry & Neuroscience, 26, 190-202.
66. Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R. et al. (1992). Phenelzine versus atenolol in social phobia. A placebo-controlled comparison. Archives of General Psychiatry, 49, 290-300.
67. Makino, S., Gold, P. W. & Schulkin, J. (1994). Corticosterone effects on corticotropin-releasing hormone mRna in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Research, 640, 105-112.
68. Mason, J. W. (1968). A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosomatic Medicine, 30, 576-607.
69. McEwen, B. S. (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338, 171-179.
70. McLeod, D. R., Hoehn-Saric, R., Foster, G. V. & Hipsley, P. A. (1993). The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder. Acta Psychiatrica Scandinavica, 888, 248-251.
71. Nater, U., Rohleder, N., Gaab, J., Berger S., Jud, A. Kirschbaum, C. & Ehlert, U. (2005). Human salivary alpha-amylase reactivity in a psychosocial stress paradigm. International Journal of Psychophysiology, 55, 333-342.
72. Neylan, T. C., Brunet, A., Pole, N., Best, S. R., Metzler, T. J., Yehuda, R. & Marmar, C. R. (2005). Psychoneuroendocrinology, 30, 373-381.
73. Olivera, A. A. & Fero, D. (1990). Affective disorders, DST, and treatment in PTSD patients: clinical observation. Journal of Traumatic Stress, 3, 407-414.
74. Palmer-Bouva, C., Costing, J., deVries, R. & Abraham-Inpijn, L. (1998). Stress in elective dental treatment: Epinephrine, norepinephrine, the VAS, and CDAS in four different procedures. General Dentistry, 46, 356-360.
75. Pauli, P., Dengler, W., Wiedemann, G., Montoya, P., Flor, H., Birbaumer, N. & Buchkremer, G. (1997). Behavioral and neurophysiological evidence for altered processing of anxiety-related words in panic disorder. Journal of Abnormal Psychology, 106, 213-220.
76. Perry, B. D., Giller, E. L. & Southwick, S. M. (1987). Altered platelet alpha-adrenergic binding sites in posttraumatic stress disorder. The American Journal of Psychiatry, 144, 1511-1512.
77. Peterson, G. A., Ballenger, J. C., Cox, D. P., Hucek, A., Lydiard, R. B., Laraia, M. T. & Trockman, C. (1985). The dexametasone suppression test in agoraphobia. Journal of Clinical Psychopharmacology, 5, 100-102.
78. Pitman, R. K., van der Kolk, B. A., Orr, S. P. & Greenberg, M. S. (1990). Naloxone-reversible analgesic response to combatrelated stimuli in posttraumatic stress disorder. Archives of General Psychiatry, 47, 541-544.
79. Plotsky, P. M., Owens, M. J. & Nemeroff, C. B. (1998). Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. The Psychiatric Clinics of North America, 21, 293-307.
80. Rohleder, N., Nater, U., Wolf, J., Ehlert, U. & Kirschbaum, C. (2004). Psychosocial stress-induced activation of salivary alpha-amylase - an indicator of sympathetic activity? Annals of the New York Academy of Sciences, 1032, 258-63.
81. Roy-Byrne, P. P., Stang, P., Wittchen, H. U., Ustun, B., Walters, E. E. & Kessler, R. C. (2000). Lifetime panic-depression comorbidity in the national comorbidity survey. Association with symptoms, impairment, course and help-seeking. The British Journal of Psychiatry, 176, 229-235.
82. Saaresranta, T. & Polo, O. (2002). Hormones and breathing. Chest, 722, 2165-2182.
83. Saß, H., Wittchen, H.-U., Zaudig, M. & Houben, I. (dt. Bearbeitung). (2003). Diagnostische Kriterien. DSM-IV-TR. Göttingen: Hogrefe.
84. Sandford, J. J., Argyropoulos, S. V. & Nutt, D. J. (2000). The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology. Pharmacology and Therapeutics, 88, 197-212.
85. Schelling, G., Kilger, E., Roozendaal, B., de Quervain, D. J.-F., Briegel, J., Dagge, A., Rothenhäusler, H.-B., Krauseneck, T., Nollert, G. & Kapfhammer, H.-P. (2004). Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: A randomized study. Biological Psychiatry, 55, 627-633.
86. 2 receptor binding potential in social phobia. The American Journal of Psychiatry, 157, 457-459.
87. Schulkin, J., Gold, P. W. & McEwen, B. S. (1998). Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology, 23, 219-243.
88. Seligman, M. E. P. (1975). Helplessness: On depression, development and death. San Francisco: Freeman.
89. Smith, M. A., Davidson, J., Ritchie, J. C., Kudler, H., Lipper, S., Chappell, P. & Nemeroff, C. B. (1989). The corticotropinreleasing hormone test in patients with posttraumatic stress disorder. Biological Psychiatry, 26, 349-355.
90. Sommer, I. & Ehlert, U. (2004). Adjustment to trauma exposure: Prevalence of posttraumatic stress disorder symptoms in Swiss mountain guides. Journal of Psychosomatic Research, 57, 329-335.
91. Soravia, L. M., Heinrichs, M., Aerni, A., Maroni, C., Schelling, G., Ehlert, U., Roozendaal, B. & de Quervain, D. J.-F. (2006). Glucocorticoids reduce phobic fear in humans. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 103, in press.
92. Southwick, S. M., Morgan, C. A. 3rd, Charney, D. S. & High, J. R. (1999). Yohimbine use in a natural setting: Effects on posttraumatic stress disorder. Biological Psychiatry, 46, 442-444.
93. Stein, M. B., Hanna, C., Koverola, C., Torchia, M. & McClarty, B. (1997 a). Structural Brain Changes in PTSD. Does trauma alter neuroanatomy? Annals of the New York Academy of Sciences, 821, 76-82.
94. Stein, M. B., Yehuda, R., Koverola, C. & Hanna, C. (1997b). Enhanced dexamethasone suppression of plasma Cortisol in adult women traumatized by childhood sexual abuse. Biological Psychiatry, 42, 680-686.
95. Ströhle, A. (2003). Die experimentelle Provokation von Panikattacken als humanexperimentelles Angstmodell. Nervenarzt, 74, 733-739.
96. Sundet, J. M., Skre, I., Okkenhaug, J. J. & Tambs, K. (2003). Genetic and environmental causes of the interrelationships between self-reported fears. A study of a non-clinical sample of Norwegian identical twins and their families. Scandinavian Journal of Psychology, 44, 97-106.
97. Tillfors, M., Furmark, T., Ekselius, L. & Fredrikson, M. (2004). Social phobia and avoidant personality disorder: one spectrum disorder? Nordic Journal of Psychiatry, 58, 147-152.
98. True, W. R., Rice, J., Eisen, S. A., Heath, A. C., Goldberg, J., Lyons, M. J. & Nowak, J. (1993). A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Archives of General Psychiatry, 50, 257-264.
99. Uhde, T. W., Joffe, R. T., Jimerson, D. C. & Post, R. M. (1988). Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biological Psychiatry, 23, 575-585.
100. Uhde, T. W., Tancer, M. E., Gelernter, C. S. & Vittone, B. J. (1994). Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. Journal of Affective Disorders, 30, 155-161.
101. Van Duinen, M. A., Schruers, K. R., Jaegers, E., Maes, M. & Griez, F. J. (2004). Salivary cortisol in panic: are males more vulnerable? Neuro Endocrinology Letters, 25, 386-390.
102. Wagner, D., Heinrichs, M. & Ehlert, U. (1998). Prevalence of PTSD symptoms in German professional firefighters. The American Journal of Psychiatry, 155, 1727-1732.
103. Yehuda, R. (1997). Sensitization of the hypothalamic-pituitaryadrenal- axis in posttraumatic stress disorder. Annals of the New York Academy of Sciences, 821, 57-75.
104. Yehuda, R., Boisoneau, D., Lowy, M. T. & Giller, E. L. (1995). Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Archives of General Psychiatry, 150, 583-593.
105. Yehuda, R., Levengood, R. A., Schmeidler, J., Wilson, S., Guo, L. S. & Gerber, D. (1996). Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology, 21, 1-16.